Nifty
Sensex
:
:
24413.50
80148.88
-65.55 (-0.27%)
-280.16 (-0.35%)

Chemicals

Rating :
36/99

BSE: 540204 | NSE: Not Listed

62.3
24-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  65.65
  •  65.65
  •  61.5
  •  63.96
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  23004
  •  1438270
  •  81.32
  •  45.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 86.35
  • 114.83
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 73.00
  • N/A
  • 1.67

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 24.40%
  • 22.65%
  • 48.92%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 4.03%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 68.38
  • 119.44
  • 15.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 57.84
  • 41.37
  • 13.05

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 54.40
  • 61.54
  • 8.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 93.27
  • 92.56
  • 97.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.99
  • 1.99
  • 1.79

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 40.45
  • 36.63
  • 35.45

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Net Sales
5.22
10.40
4.25
2.34
Net Sales Growth
-40.48%
144.71%
81.62%
 
Cost Of Goods Sold
3.43
7.61
3.07
1.37
Gross Profit
1.79
2.79
1.17
0.96
GP Margin
34.23%
26.83%
27.53%
41.03%
Total Expenditure
7.40
14.91
4.95
2.02
Power & Fuel Cost
-
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
Employee Cost
-
2.58
0.78
0.18
% Of Sales
-
24.81%
18.35%
7.69%
Manufacturing Exp.
-
2.94
0.62
0.21
% Of Sales
-
28.27%
14.59%
8.97%
General & Admin Exp.
-
1.42
0.47
0.22
% Of Sales
-
13.65%
11.06%
9.40%
Selling & Distn. Exp.
-
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
Miscellaneous Exp.
-
0.36
0.00
0.03
% Of Sales
-
3.46%
0%
1.28%
EBITDA
-2.18
-4.51
-0.70
0.32
EBITDA Margin
-41.76%
-43.37%
-16.47%
13.68%
Other Income
0.03
0.01
0.06
0.09
Interest
0.22
0.24
0.19
0.09
Depreciation
0.18
0.19
0.17
0.08
PBT
-2.54
-4.93
-1.00
0.25
Tax
-0.69
-1.31
-0.21
0.05
Tax Rate
27.17%
26.57%
21.00%
20.00%
PAT
-1.85
-1.91
-0.44
0.20
PAT before Minority Interest
-0.99
-3.62
-0.78
0.20
Minority Interest
0.86
1.71
0.34
0.00
PAT Margin
-35.44%
-18.37%
-10.35%
8.55%
PAT Growth
0.00%
-
-
 
EPS
-1.33
-1.37
-0.32
0.14

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Shareholder's Funds
2.95
4.92
5.56
Share Capital
3.82
3.82
3.82
Total Reserves
-0.87
1.10
1.74
Non-Current Liabilities
-0.02
0.15
0.51
Secured Loans
1.61
0.42
0.48
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Current Liabilities
9.33
4.08
4.66
Trade Payables
3.85
1.40
2.29
Other Current Liabilities
5.45
1.68
1.05
Short Term Borrowings
0.00
0.94
1.27
Short Term Provisions
0.04
0.05
0.06
Total Liabilities
10.43
9.03
10.95
Net Block
1.75
1.71
1.68
Gross Block
2.68
2.45
2.27
Accumulated Depreciation
0.93
0.74
0.58
Non Current Assets
5.39
4.86
4.98
Capital Work in Progress
0.00
0.00
0.00
Non Current Investment
0.10
1.72
3.17
Long Term Loans & Adv.
2.09
0.05
0.04
Other Non Current Assets
1.45
1.37
0.08
Current Assets
5.03
4.17
5.98
Current Investments
0.00
0.00
0.00
Inventories
3.21
2.31
3.10
Sundry Debtors
1.18
0.86
1.46
Cash & Bank
0.02
0.11
0.80
Other Current Assets
0.61
0.31
0.04
Short Term Loans & Adv.
0.47
0.58
0.57
Net Current Assets
-4.30
0.09
1.32
Total Assets
10.42
9.03
10.96

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
-0.33
0.16
0.00
PBT
-4.93
-1.00
0.00
Adjustment
0.36
0.34
0.00
Changes in Working Capital
4.27
0.84
0.00
Cash after chg. in Working capital
-0.30
0.19
0.00
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.02
-0.02
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-0.71
-0.30
0.00
Net Fixed Assets
0.00
0.00
Net Investments
1.63
1.45
Others
-2.34
-1.75
Cash from Financing Activity
0.95
-0.55
0.00
Net Cash Inflow / Outflow
-0.09
-0.69
0.00
Opening Cash & Equivalents
0.11
0.80
0.00
Closing Cash & Equivalent
0.02
0.11
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
7.71
12.89
14.56
ROA
-37.22%
-7.85%
1.83%
ROE
-92.01%
-14.96%
3.61%
ROCE
-86.53%
-11.96%
4.56%
Fixed Asset Turnover
4.05
1.80
1.03
Receivable days
35.79
99.91
228.50
Inventory Days
96.92
232.74
484.30
Payable days
70.22
168.32
494.04
Cash Conversion Cycle
62.50
164.33
218.75
Total Debt/Equity
0.55
0.28
0.31
Interest Cover
-19.34
-4.39
3.82

News Update:


  • Eiko LifeSciences incorporates limited liability partnership
    31st May 2024, 10:41 AM

    The company has incorporated Limited Liability Partnership on May 30, 2024

    Read More
  • Eiko Lifesciences - Quarterly Results
    13th May 2024, 18:25 PM

    Read More
  • Eiko LifeSciences acquires 25.01% stake in Reflux Pharmaceuticals
    19th Apr 2024, 14:29 PM

    Pursuant to the said acquisition, RPPL has become an Associate Company of Eiko Lifesciences

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.